Prescription drug · UNAPPROVED DRUG OTHER
Inflatherm NDC 72835-701
diclofenac sodium and menthol / camphor gel · Kit · V2 Pharma, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72835-701-02 | 7283507010272835070102 | 1 KIT in 1 CARTON (72835-701-02) * 60 TABLET, DELAYED RELEASE in 1 BOTTLE (0228-2551-06) * 85 g in 1 BOTTLE, PLASTIC (61577-3234-5)Marketed from Aug 13, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Inflatherm
- Generic name (nonproprietary)
- diclofenac sodium and menthol / camphor gel
- Dosage form
- Kit
- Labeler
- V2 Pharma, LLCNDC labeler code 72835
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Identifiers
- Product ID 72835-701_a46631b9-de3b-414d-94ae-c6352f4812c8SPL ID a46631b9-de3b-414d-94ae-c6352f4812c8SPL set ID b62f4306-8dbd-4501-8b1e-9aa78f9aee06RxCUI 630714, 855926UPC 0763669142039, 0302282551066
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N472835070102followed by a unit qualifier and the quantityPackage 72835-0701-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets and other treatment options before deciding to use diclofenac sodium delayed-release tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS; Gastrointestinal Bleeding, Ulceration, and Perforation ) . Diclofenac sodium delayed-release tablets, USP are indicated: For relief of the signs and symptoms of osteoarthritis For relief of the signs and symptoms of rheumatoid arthritis For acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis
Excerpt only. Read the full label for complete information.
About NDC 72835-701
- What is NDC 72835-701?
- 72835-701 is the product NDC for Inflatherm kit, listed with the FDA by V2 Pharma, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Inflatherm (Diclofenac Sodium and Menthol / Camphor Gel).
- Who is the labeler?
- V2 Pharma, LLC, NDC labeler code 72835. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Inflatherm?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.